> For the complete documentation index, see [llms.txt](https://www.thiamine.wiki/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://www.thiamine.wiki/thiamine-basics/thiamine-basics/introduction-to-thiamine/4.-biochemistry/molecular-structure.md).

# molecular structure

{% hint style="info" %}
**Section:** Complete Biochemistry → Molecular Structure & Chemistry\
**Reading level:** Technical, with a plain-language summary\
**Last reviewed:** October 2026
{% endhint %}

## Summary

Thiamine is a small molecule built from two heterocyclic rings, an **aminopyrimidine** and a **thiazolium**, joined by a single methylene (–CH₂–) bridge. The thiazolium nitrogen is quaternary, so thiamine carries a **permanent positive charge** at every physiological pH. This charge explains why thiamine needs transporter proteins to cross membranes. It also explains why the lipid-soluble derivatives all work by temporarily opening the thiazolium ring.

The catalytic heart of thiamine is the **C2 carbon of the thiazolium ring**. When thiamine is bound to an enzyme as thiamine pyrophosphate (TPP), this carbon loses its proton to become a highly reactive carbanion. That carbanion allows TPP-dependent enzymes to break and form carbon–carbon bonds next to carbonyl groups.

## Key facts

| Property                               | Value                                                                                                          |
| -------------------------------------- | -------------------------------------------------------------------------------------------------------------- |
| **IUPAC name (cation)**                | 3-\[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium                      |
| **Formula (cation)**                   | C₁₂H₁₇N₄OS⁺                                                                                                    |
| **Molar mass (cation)**                | ≈265.4 g/mol                                                                                                   |
| **SMILES (cation)**                    | `Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1`                                                                              |
| **Permanent charge**                   | +1 (quaternary thiazolium N3)                                                                                  |
| **Pyrimidine N1′ pKa (free thiamine)** | ≈5 (protonated in strong acid, neutral at physiological pH)                                                    |
| **C2–H acidity**                       | Very weak in water (pKa estimated around 18), but strongly enhanced in enzymes                                 |
| **Phosphorylation site**               | Terminal hydroxyl of the 5-(2-hydroxyethyl) side chain                                                         |
| **CAS numbers**                        | Thiamine hydrochloride 67-03-8; thiamine mononitrate 532-43-4; thiamine pyrophosphate (cocarboxylase) 154-87-0 |

## Architecture and numbering

| Part                        | Description                                                             | Atoms (conventional numbering)                                                 |
| --------------------------- | ----------------------------------------------------------------------- | ------------------------------------------------------------------------------ |
| **Aminopyrimidine ring**    | 4-amino-2-methylpyrimidine, attached at C5′                             | Primed numbers: N1′, C2′, N3′, C4′ (bearing the 4′-amino group, N4′), C5′, C6′ |
| **Methylene bridge**        | Single –CH₂– linking C5′ of the pyrimidine to N3 of the thiazolium      | C3,5′ (or C7′)                                                                 |
| **Thiazolium ring**         | 4-methyl-5-(2-hydroxyethyl)thiazolium, attached via N3                  | Unprimed numbers: S1, C2, N3, C4, C5                                           |
| **Hydroxyethyl side chain** | On C5 of the thiazolium; esterified with phosphate in TMP, TPP and ThTP | —                                                                              |

By convention, pyrimidine atoms carry a prime (′) and thiazolium atoms do not. This numbering is used throughout the enzymology literature, so it is worth learning.

{% hint style="info" %}
**Figure suggestion:** a labelled 2D structure of thiamine and TPP, with N1′, N4′, C2 and N3 marked, is the single most useful image for this page. Public-domain structure images are available from Wikimedia Commons and PubChem.
{% endhint %}

## Charge and ionization states

Thiamine has one permanent charge and several sites whose charge depends on pH.

| Site                                  | Behaviour                                                                                 | Consequence                                                                                               |
| ------------------------------------- | ----------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------- |
| **N3 (thiazolium)**                   | Quaternary; always positive                                                               | Thiamine is always a cation; it cannot diffuse freely through lipid membranes at dietary concentrations   |
| **N1′ (pyrimidine)**                  | Basic; pKa ≈5 in free thiamine                                                            | Protonated in stomach acid (thiamine becomes a dication); neutral at blood pH                             |
| **4′-amino group (N4′)**              | Not basic in the usual sense (conjugated with the ring); can tautomerize to an imino form | The 1′,4′-iminopyrimidine tautomer acts as an internal base in enzyme catalysis                           |
| **C2–H (thiazolium)**                 | Very weakly acidic in water                                                               | Deprotonation gives the ylide (carbene) that performs catalysis                                           |
| **Phosphate esters (TMP, TPP, ThTP)** | Strongly acidic phosphate groups                                                          | Phosphorylated forms are net negatively charged at physiological pH; TPP carries a net charge of about −2 |

### Charge by environment

| Environment                     | Approximate pH | Dominant form of free thiamine                            | Net charge |
| ------------------------------- | -------------- | --------------------------------------------------------- | ---------- |
| Stomach                         | 1–3            | N1′-protonated dication                                   | +2         |
| Small intestine, blood, cytosol | 6–7.5          | Monocation                                                | +1         |
| Strongly alkaline solution      | > 9            | Increasingly converted to the ring-opened thiol(ate) form | 0 or −1    |

Commercial **thiamine chloride hydrochloride** crystallizes as the dication with two chloride counter-ions, which is why its solutions are acidic (see [Thiamine Salts & Forms](broken://pages/63930e1e9ba757591e0d33d51c63efada787f463)).

### Ring opening in alkaline conditions

Above roughly neutral pH, hydroxide ions can attack C2. This forms an unstable pseudobase and then opens the thiazolium ring to give the **thiol form** (an open-chain N-formyl thiol). The reaction is reversible: on acidification the ring closes again to regenerate thiamine.

This chemistry matters for three reasons:

* It underlies thiamine's **instability in alkaline foods and solutions** (see [Stability, Degradation & Metabolism](broken://pages/76c27f4ff7c1d2df66615a8966cc4529e4549346)).
* Oxidation of the open form produces **thiochrome**, a fluorescent compound used to measure thiamine by HPLC.
* All **lipid-soluble thiamine derivatives** (disulfides such as sulbutiamine and TTFD, and thioesters such as benfotiamine and dibenzoylthiamine) are chemically "locked" versions of the open thiol form. Once the lock is removed inside the body, the ring closes back to thiamine (see [Thiamine Derivatives](broken://pages/42dac8ecc888b0d7e0b1a0677aa37bd14cf30e88)).

## Conformations

Rotation around the two bonds of the methylene bridge allows the rings to adopt different relative orientations, classified as **F**, **S** and **V** conformations according to two torsion angles (φT and φP).

| Conformation | Where it is seen                               | Significance                                                                                                             |
| ------------ | ---------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------ |
| **F**        | Most crystal structures of free thiamine salts | Rings roughly perpendicular                                                                                              |
| **S**        | Some C2-substituted thiamine derivatives       | Steric effects of C2 substituents                                                                                        |
| **V**        | Essentially all enzyme-bound TPP               | Brings the 4′-nitrogen within about 3.5 Å of C2, allowing the pyrimidine to act as an internal base for C2 deprotonation |

The V conformation is enforced by the enzyme. It is a key reason TPP is catalytically far more powerful when bound to a protein than in free solution.

## Why thiamine is a catalyst: the C2 carbanion

In 1958, Ronald Breslow proposed that the C2 proton of the thiazolium ring is removed to generate a carbanion (now often described as an **ylide** or **N-heterocyclic carbene**). This species attacks carbonyl carbons. In water, C2 deprotonation is very slow, but enzymes accelerate it by many orders of magnitude.

Current understanding of the activation sequence in enzymes:

{% stepper %}
{% step %}

### A conserved glutamate residue hydrogen-bonds to and protonates N1′

{% endstep %}

{% step %}

### This favours the 1′,4′-iminopyrimidine tautomer

In this tautomer, N4′ is a stronger base.
{% endstep %}

{% step %}

### N4′ removes the C2 proton

Held close by the V conformation, **N4′ removes the C2 proton**, generating the ylide.
{% endstep %}

{% step %}

### The ylide attacks the substrate's carbonyl carbon

This forms a covalent adduct.
{% endstep %}

{% step %}

### Subsequent steps depend on the enzyme

These may include decarboxylation, C–C cleavage, oxidation or transfer.
{% endstep %}
{% endstepper %}

Nuclear magnetic resonance studies in 1997 showed directly that enzyme binding speeds up C2–H exchange dramatically. Spectroscopic work since then has defined the ionization and tautomeric states of the cofactor at individual catalytic steps.

{% hint style="info" %}
**Beyond biology:** thiazolium and related N-heterocyclic carbenes are widely used as catalysts in synthetic organic chemistry, for example in the benzoin condensation. This field grew directly from model studies of thiamine catalysis.
{% endhint %}

## How TPP binds to enzymes

TPP-dependent enzymes share a conserved diphosphate-binding motif, **GDG(X)₂₄–₂₇NN**, first identified in 1989. A divalent metal ion (usually Mg²⁺, sometimes Ca²⁺) bridges the diphosphate to the protein. The pyrimidine ring binds in a separate pocket, usually contributed by a second subunit. The active site therefore sits at a subunit interface, which is why TPP enzymes function as dimers or larger assemblies. See [TPP-Dependent Enzymes](broken://pages/d71780053dc147c5f7e930230f278e44f0028b7b).

## Structure–activity relationships

Modified thiamine molecules show which parts of the structure are essential. Several of these analogues are used as research tools.

| Analogue                                  | Modification                                   | Effect                                                                                                                                                  |
| ----------------------------------------- | ---------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------- |
| **Oxythiamine**                           | 4′-amino replaced by hydroxyl                  | Phosphorylated to oxythiamine pyrophosphate, which binds enzymes but cannot support catalysis; an inhibitor of transketolase and pyruvate dehydrogenase |
| **Pyrithiamine**                          | Thiazolium replaced by a pyridinium ring       | Antagonist; inhibits thiamine pyrophosphokinase and binds TPP riboswitches in microbes; used to induce thiamine deficiency in animal models             |
| **Amprolium**                             | Picolinium ring; lacks the hydroxyethyl group  | Competitively inhibits thiamine transport; used as an anticoccidial agent in veterinary medicine                                                        |
| **3-Deazathiamine (and its diphosphate)** | N3 replaced by carbon (neutral thiophene ring) | Mimics the ylide; binds TPP enzymes very tightly and inhibits them                                                                                      |

These examples confirm that the **4′-amino group**, the **thiazolium ring** and the **hydroxyethyl side chain** are each required for normal coenzyme function.

## Detection and measurement

* **Thiochrome method:** oxidation of thiamine and its phosphate esters in alkaline solution (classically with potassium ferricyanide) yields thiochrome derivatives that fluoresce blue (excitation ≈365 nm, emission ≈435 nm). This is the basis of most HPLC methods for measuring thiamine, TMP, TPP and ThTP.
* **UV absorbance and circular dichroism:** used in research to follow the tautomeric states of enzyme-bound TPP.
* **Mass spectrometry:** increasingly used for thiamine and its derivatives in research and some clinical laboratories.

## Open questions

* How individual enzymes tune the pKa values of N1′, N4′ and C2 to match their particular reactions.
* Whether free (unbound) thiamine compounds interact with proteins through mechanisms related to these charge properties (see [Non-Coenzyme Roles](broken://pages/888635b361ff9f1136c233c1418fce25f1f97c07)).

## Related pages

* [Stability, Degradation & Metabolism](broken://pages/76c27f4ff7c1d2df66615a8966cc4529e4549346)
* [Thiamine Salts & Forms](broken://pages/63930e1e9ba757591e0d33d51c63efada787f463)
* [TPP-Dependent Enzymes](broken://pages/d71780053dc147c5f7e930230f278e44f0028b7b)
* [Thiamine Derivatives](broken://pages/42dac8ecc888b0d7e0b1a0677aa37bd14cf30e88)
* [What Is Thiamine?](broken://pages/102a89b556da7ad04f369c628102ed68e55c16d8)

## References

1. Williams RR. Structure of vitamin B1. *Journal of the American Chemical Society*. 1936;58(6):1063–1064.
2. Breslow R. On the mechanism of thiamine action. IV. Evidence from studies on model systems. *Journal of the American Chemical Society*. 1958;80(14):3719–3726.
3. Washabaugh MW, Jencks WP. Thiazolium C(2)-proton exchange: structure-reactivity correlations and the pKa of thiamin C(2)-H revisited. *Biochemistry*. 1988;27(14):5044–5053.
4. Hawkins CF, Borges A, Perham RN. A common structural motif in thiamin pyrophosphate-binding enzymes. *FEBS Letters*. 1989;255(1):77–82.
5. Kern D, et al. How thiamine diphosphate is activated in enzymes. *Science*. 1997;275(5296):67–70.
6. Jordan F. Current mechanistic understanding of thiamin diphosphate-dependent enzymatic reactions. *Natural Product Reports*. 2003;20(2):184–201.
7. Nemeria NS, Chakraborty S, Balakrishnan A, Jordan F. Reaction mechanisms of thiamin diphosphate enzymes: defining states of ionization and tautomerization of the cofactor at individual steps. *FEBS Journal*. 2009;276(9):2432–2446.
8. Manzetti S, Zhang J, van der Spoel D. Thiamin function, metabolism, uptake, and transport. *Biochemistry*. 2014;53(5):821–835.
9. Lu J, Frank EL. Rapid HPLC measurement of thiamine and its phosphate esters in whole blood. *Clinical Chemistry*. 2008;54(5):901–906.

{% hint style="info" %}
**Editorial note:** This page describes mechanisms and published evidence. It is not medical advice and does not recommend doses. Suggest corrections or new sources via the feedback link.
{% endhint %}
